Adult

Cefotaxime

Warning

General Information

Third generation cephalosporin antibiotic

Do NOT use if patient has a history of severe penicillin allergy.  If in doubt, discuss with Micro/ID.

Formulary antimicrobial: Use in accordance with Trust guidelines 

AWaRe antibiotic classification: 'Watch'. Use as per guidelines. All other indications to be discussed with Micro/ID.

For all information regarding interactions, contraception, pregnancy and breastfeeding and additional information, see BNF.

Dosing

  Intravenous dose
Standard dose 1g BD-TDS
Severe infection

2g QDS

(Maximum 12g per day)

Obesity

No dose adjustment required

Renal and hepatic impairment

Renal impairment

eGFR (mL/min/1.73m2)

Dose

5 and above

Dose as in normal renal function

Less than 5

Initial dose of 1g then use half normal dose and keep frequency the same

HD/HDF/High Flux

Dialysed; give post-dialysis on dialysis days

Dose as in eGFR less than 5 mL/min/1.73m2

PD

Not dialysed

Dose as in eGFR less than 5 mL/min/1.73m2

 

Hepatic impairment

No dose adjustment required.

References

  1. Bowmed Ibisqus Limited. Cefotaxime 500mg powder for solution for injection/infusion vials summary of product characteristics. Electronic medicines compendium. Last revision of the text 25/6/24. Accessed via www.medicines.org.uk Accessed 5/3/26.
  2. British National Formulary. Cefotaxime. BNF online accessed via www.medicinescomplete.com  Accessed 5/3/26.
  3. The Renal Drug Database. Cefotaxime. Last updated 29/10/24. Accessed via https://renaldrugdatabase.com Accessed 5/3/26.
  4. All-Wales Antimicrobial Pharmacists’ Group (2022) Antimicrobial dosing in extremes of body weight in adults. Accessed 5/3/26.
  5. Sanford guide [online]. Cefotaxime. Last updated 2/12/25. Accessed via https://webedition.sanfordguide.com Accessed 5/3/26.

Editorial Information

Last reviewed: 05 Mar 2026

Next review date: 04 Mar 2029

Author(s): AMST.